Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 1.32.

  • Niagen Bioscience's Asset Utilization Ratio fell 2069.85% to 1.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.32, marking a year-over-year decrease of 2069.85%. This contributed to the annual value of 1.62 for FY2024, which is 542.59% up from last year.
  • As of Q3 2025, Niagen Bioscience's Asset Utilization Ratio stood at 1.32, which was down 2069.85% from 1.35 recorded in Q2 2025.
  • Niagen Bioscience's Asset Utilization Ratio's 5-year high stood at 1.66 during Q3 2024, with a 5-year trough of 1.03 in Q3 2021.
  • Its 5-year average for Asset Utilization Ratio is 1.43, with a median of 1.45 in 2022.
  • As far as peak fluctuations go, Niagen Bioscience's Asset Utilization Ratio surged by 4459.08% in 2022, and later plummeted by 2069.85% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Asset Utilization Ratio stood at 1.14 in 2021, then rose by 26.71% to 1.45 in 2022, then rose by 6.66% to 1.54 in 2023, then increased by 3.56% to 1.6 in 2024, then fell by 17.61% to 1.32 in 2025.
  • Its Asset Utilization Ratio stands at 1.32 for Q3 2025, versus 1.35 for Q2 2025 and 1.44 for Q1 2025.